Eurolac

PRESENTATION:

Eurolac 10 tablet: Each film coated tablet contains Ketorolac tromethamine USP 10 mg.

Eurolac 30 injection: Each 1 ml injection contains 30 mg Ketorolac tromethamine USP.

Eurolac 60 injection: Each 2 ml injection contains 60 mg Ketorolac tromethamine USP.

INDICATION:

Ketorolac Tromethamine is indicated for the short-term (<5 days) management of moderately severe acute pain that requires analgesia at the opioid level, (usually in postoperative setting). Therapy should always be started with Ketorolac Tromethamine IM/IV injection and Ketorolac Tromethamine oral is to be used only as continuation treatment, if necessary. Combined use of Ketorolac Tromethamine IM/IV and oral is not to exceed 5 days of use because of the potential of increasing the frequency and severity of adverse reactions associated with the recommended doses.

PACKAGING:

Eurolac 10 tablet: Box containing 3 x 10 tablets in Alu-Alu blister pack.

Eurolac 30 injection: Each box contains 1 blister pack of 1 ampoule of 1 ml sterile solution for Injection of Ketorolac Tromethamine 30 mg.

Eurolac 60 injection: Each box contains 1 blister pack of 1 ampoule of 2 ml sterile solution for Injection of Ketorolac Tromethamine 60 mg.